ReviewEmerging infectious diseases2016
Patient Report and Review of Rapidly Growing Mycobacterial Infection after Cardiac Device Implantation.
Review in Emerging infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- Tuberculosis and the Heart.Journal of the American Heart Association · 2021Pooled it
- Mycobacterium smegmatis Infection in a Cardiovascular Implantable Electronic Device in an Immunocompetent Patient.Cureus · 2026Article
- Injectable ε-poly-lysine/hyaluronic acid hydrogel for targeted prevention of cardiovascular implantable electronic device pocket infections.RSC advances · 2026Article
- Matters of the heart: A scoping review toward better management of nontuberculous mycobacterial infections of cardiac devices.Journal of clinical tuberculosis and other mycobacterial diseases · 2025Article
- Incidence of secondary pericardial effusions associated with different etiologies: a comprehensive review of literature.Journal of cardiothoracic surgery · 2025Review
- Cardiovascular device infections due to rapidly growing Mycobacteria: A review of cases at a tertiary care hospital.Journal of clinical tuberculosis and other mycobacterial diseases · 2022Article
- Rare enough ? Cardiac Device-related pocket Infection due toClinical case reports · 2021Article
- Complete Genome Sequence ofMicrobiology resource announcements · 2020Article
- Contemporary Management Strategies in VAD Infection.Current heart failure reports · 2020Review
- Rare case of pacemaker infection withBMJ case reports · 2019Article
- Cardiovascular implantable electronic device infection with rapidly growing mycobacteria.Proceedings (Baylor University. Medical Center) · 2019Article
- Cardiac resynchronization therapy-defibrillator pocket infection caused by Mycobacterium fortuitum: a case report and review of the literature.BMC cardiovascular disorders · 2019Review
- Cardiac implantable electronic device infection in the cardiac referral center in Thailand: incidence, microbiology, risk factors, and outcomes.Journal of arrhythmia · 2018Article
- [Pacemaker infection with Mycobacterium neoaurum].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2018Article
- Implantable cardiac defibrillator infections: the emerging importance ofBMJ case reports · 2017Article
- Evaluation of GenoType NTM-DR Assay for Identification of Mycobacterium chimaera.Journal of clinical microbiology · 2017Article
- Pacemaker pocket infection due to Mycobacterium goodii, a rapidly growing mycobacteria.BMJ case reports · 2017Article
- Driveline Infection in Ventricular Assist Devices and Its Implication in the Present Era of Destination Therapy.Open journal of cardiovascular surgery · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Mycobacterial infections resulting from cardiac implantable electronic devices are rare, but as more devices are implanted, these organisms are increasingly emerging as causes of early-onset infections. We report a patient with an implantable cardioverter-defibrillator pocket and associated bloodstream infection caused by an organism of the Mycobacterium fortuitum group, and we review the literature regarding mycobacterial infections resulting from cardiac device implantations. Thirty-two such infections have been previously described; most (70%) were caused by rapidly growing species, of which M. fortuitum group species were predominant.When managing such infections, clinicians should consider the potential need for extended incubation of routine cultures or dedicated mycobacterial cultures for accurate diagnosis; combination antimicrobial drug therapy, even for isolates that appear to be macrolide susceptible, because of the potential for inducible resistance to this drug class; and the arrhythmogenicity of the antimicrobial drugs traditionally recommended for infections caused by these organisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.